ArticleRadiology and oncology2014

Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab.

Robert Königsberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.